![Richard Williams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Williams
Directeur Technique/Scientifique/R&D chez
CannBioRex Pharmaceuticals Corp.
Profil
Richard Williams currently works as a Professor at the Kennedy Institute of Rheumatology.
He is currently the Chief Scientific Officer at CannBioRex Pharmaceuticals Corp.
Postes actifs de Richard Williams
| Sociétés | Poste | Début |
|---|---|---|
CannBioRex Pharmaceuticals Corp.
 CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel synthetic pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/05/2018 |
Kennedy Institute of Rheumatology
 Kennedy Institute of Rheumatology Pharmaceuticals: MajorHealth Technology Operates translational inflammatory sciences centre, which focuses on understanding the causes of chronic inflammatory conditions to develops new treatments | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Kennedy Institute of Rheumatology
Kennedy Institute of Rheumatology Pharmaceuticals: MajorHealth Technology Operates translational inflammatory sciences centre, which focuses on understanding the causes of chronic inflammatory conditions to develops new treatments | Health Technology |
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel synthetic pharmaceutical products | Health Technology |
